Why Indian bulk-drug makers are attracting greater investor interest
Advertisement

Why Indian bulk-drug makers are attracting greater investor interest

Premium
Why Indian bulk-drug makers are attracting greater investor interest
Credit: Thinkstock

Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk...

This is a Premium article, Subscribe to read the full story!

Limited Time Offer - Subscribe now & get free access to The Unicorn report.

The year 2021 was a record year for Unicorn activity in India, with 47 new Unicorns being added to the list, from a previous 11 in 2020. Get access to exclusive analysis on growth landscape, sectoral view, future Unicorns & more..

Advertisement
Advertisement